Episode 99: Tiotropium, ACCORD and that's it

Submitted by admin on Wed, 2010-09-29 18:34

In episode 99, Mike and James shed light on two useful new trials. We breath air into what to do with patients with asthma who don't respond completely to inhaled corticosteroids and we take a close look with improved visual acuity at the microvascular data from ACCORD.

The full content of this Podcast, including the audio file, is available to Premium Members only. Click to find out the benefits of having a Premium Membership.

Why Get A Premium Membership ?

Comments

In the vein of 2), & 3), I

Submitted by nevermind701 (not verified) on Thu, 2010-09-30 01:14.

In the vein of 2), & 3), I would like to add this editorial:
http://www.bmj.com/content/340/bmj.c3188.full

Hi - I'd seen this editorial

Submitted by JPM on Thu, 2010-09-30 06:56.

Hi - I'd seen this editorial - I couldn't agree more. This is just another thing that makes well people sick.

Hi James and Mark. I read the

Submitted by javidoc (not verified) on Wed, 2010-10-06 00:17.

Hi James and Mark.
I read the literature again and again and i wonder why if diabetes is a coronary risk equivalent they included diabetic patient in primary prevention studies. Why don´t they include diabetes patients without events in secondary prev studies?
Statins metanalysis in primary prevention are based in trials with too many sick people. Never the opposite (healthy people in secondary prev).
Is it contradictory or i have to read more english to better understand whay they mean?
Listening your podcast is my happy way to go to my hospital.
Saludos de Argentina

Post new comment

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.